Page 7 - Nasdaq Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Axsm Today - Breaking & Trending Today

Axsome Therapeutics' (AXSM) Outperform Rating Reaffirmed at William Blair

William Blair reiterated their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note issued to investors on Monday morning, RTT News reports. A number of other analysts have also issued reports on the company. Mizuho boosted their price target on Axsome Therapeutics from $84.00 to $95.00 in a report […] ....

United States , William Blair , Axsome Therapeutics Inc , International Biotechnology Trust , Oak Ridge Investments , Morgan Stanley , Principal Financial Group Inc , Axsome Therapeutics , Free Report , Moderate Buy , Get Free Report , Biotechnology Trust , Financial Strategies , Financial Group , Axsome Therapeutics Daily , Nasdaq Axsm , Reiterated Rating ,

Envestnet Asset Management Inc. Sells 1,548 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Envestnet Asset Management Inc. reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.9% in the 1st quarter, HoldingsChannel.com reports. The fund owned 10,473 shares of the company’s stock after selling 1,548 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Axsome Therapeutics were worth $646,000 at the end […] ....

United States , Axsome Therapeutics Company Profile , Envestnet Asset Management Inc , Morgan Stanley , Jpmorgan Chase Co , Axsome Therapeutics Inc , Raymond James Financial Services Advisors Inc , Panagora Asset Management Inc , Sei Investments Co , Metlife Investment Management , Envestnet Asset Management , Axsome Therapeutics , Free Report , Asset Management , James Financial Services Advisors , Life Investment Management , Sei Investments , Get Free Report , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

HC Wainwright Lowers Axsome Therapeutics (NASDAQ:AXSM) Price Target to $190.00

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price decreased by equities research analysts at HC Wainwright from $200.00 to $190.00 in a research report issued to clients and investors on Monday, FlyOnTheWall reports. HC Wainwright’s price objective indicates a potential upside of 156.17% from the stock’s current price. AXSM has been the […] ....

United States , Morgan Stanley , Axsome Therapeutics Inc , Vanguard Group Inc , Axsome Therapeutics , Get Free Report , State Street Corp , Street Corp , Axsome Therapeutics Daily , Nasdaq Axsm , Lower Price Target , Hc Wainwright ,

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 2.5%

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report)’s share price rose 2.5% during mid-day trading on Thursday . The stock traded as high as $74.64 and last traded at $74.57. Approximately 480,521 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 926,140 shares. The stock had previously closed at […] ....

United States , Axsome Therapeutics Inc , Jpmorgan Chase Co , Sei Investments Co , Morgan Stanley , Raymond James Financial Services Advisors Inc , Axsome Therapeutics Company Profile , Metlife Investment Management , Panagora Asset Management Inc , Axsome Therapeutics , Free Report , James Financial Services Advisors , Life Investment Management , Asset Management , Sei Investments , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been given an average recommendation of “Moderate Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and ten have assigned a buy recommendation to the […] ....

United States , Tower Research Capital , China Universal Asset Management Co , Armstrong Advisory Group Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Morgan Stanley , Axsome Therapeutics , Get Rating , Financial Advisors , Advisory Group , Universal Asset Management , Research Capital , Dark Forest Capital Management , Therapeutics Trading Down , Axsome Therapeutics Daily , Nasdaq Axsm ,